Regarding the positive association of CRP with cardiovascular disease, such as myocardial infarction and stroke, the lowering of its levels indicates a “pleiotropic”, anti-inflammatory effect of RET in this chronic systemic, low-grade inflammatory condition, with potential benefit in the future [41]. The gene discussed is CRP; the disease is Stroke.